BioLineRx Ltd. (BLRX) Capital expenditures 2016–2025
BioLineRx Ltd. (BLRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$25,000FY2025 · since FY2016: $52,000 → $25,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25,000 | -52.8% |
| FY2024 | $53,000 | -54.3% |
| FY2023 | $116,000 | -11.5% |
| FY2022 | $131,000 | +35.1% |
| FY2021 | $97,000 | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $67,000 | -61.3% |
| FY2018 | $173,000 | -48.8% |
| FY2017 | $338,000 | +550.0% |
| FY2016 | $52,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice